Brief Communication: Copper suppression of vascular endothelial growth factor receptor-2 is involved in the regression of cardiomyocyte hypertrophy

Experimental Biology and Medicine

Volumn 239, Issue 8, 2014, Pages 948-953

  Wang, Tao ^a   Li, Rui ^a   Lin, Chen ^a   Sun, Miao ^a   Kang, Y James ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cardiomyocyte; Copper; hypertrophy; VEGF; VEGFR 1; VEGFR 2

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; COPPER SULFATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; PHENYLEPHRINE; RIBOSOME PROTEIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MUSCLE HYPERTROPHY; NEWBORN; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84907064592     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214536119     Document Type: Article

References (30)

1. Shyu KG,Liou JY,Wang BW,Fang WJ,Chang H.Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart.J Biomed Sci. 2005;12:409-20
2. Shimojo N,Jesmin S,Zaedi S,Otsuki T,Maeda S,Yamaguchi N,Aonuma K,Hattori Y,Miyauchi T.Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy.Am J Physiol Heart Circ Physiol. 2007;293:H474-81
3. Sano M,Minamino T,Toko H,Miyauchi H,Orimo M,Qin Y,Akazawa H,Tateno K,Kayama Y,Harada M,Shimizu I,Asahara T,Hamada H,Tomita S,Molkentin JD,Zou Y,Komuro I.P53-induced inhibition of HIF-1 causes cardiac dysfunction during pressure overload.Nature. 2007;446:444-8
4. Jiang Y,Reynolds C,Xiao C,Feng W,Zhou Z,Rodriguez W,Tyagi SC,Eaton JW,Saari JT,Kang YJ.Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice.J Exp Med. 2007;204:657-66
5. Zhou Y,Jiang Y,Kang YJ.Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size.J Mol Cell Cardiol. 2008;45:106-17
6. Zhou Y,Bourcy K,Kang YJ.Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway.Cardiovasc Res. 2009;84:54-63
7. Takahashi T,Ueno H,Shibuya M.VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.Oncogene. 1999;18:2221-30
8. Kroll J,Waltenberger J.The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells.J Biol Chem. 1997;272:32521-7
9. Seko Y,Takahashi N,Tobe K,Ueki K,Kadowaki T,Yazaki Y.Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes.J Cell Physiol. 1998;175:239-46
10. Izumiya Y,Shiojima I,Sato K,Sawyer DB,Colucci WS,Walsh K.Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.Hypertension. 2006;47:887-93
11. Clerk A,Sugden PH.Activation of protein kinase cascades in the heart by hypertrophic G protein coupled receptor agonists.Am J Cardiol. 1999;83:64H-9H
12. DeBosch B,Treskov I,Lupu TS,Weinheimer C,Kovacs A,Courtois M,Muslin AJ.Akt1 is required for physiological cardiac growth.Circulation. 2006;113:2097-104
13. Bueno OF,De Windt LJ,Tymitz KM,Witt SA,Kimball TR,Klevitsky R,Hewett TE,Jones SP,Lefer DJ,Peng CF,Kitsis RN,Molkentin JD.The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.EMBO J. 2000;19:6341-50
14. Fiedler B,Lohmann SM,Smolenski A,Linnemuller S,Pieske B,Schroder F,Molkentin JD,Drexler H,Wollert KC.Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.Proc Natl Acad Sci. 2002;99:11363-8
15. Wollert KC,Fiedler B,Gambaryan S,Smolenski A,Heineke J,Butt E,Trautwein C,Lohmann SM,Drexler H.Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.Hypertension. 2002;39:87-92
16. Takimoto E,Champion HC,Li M,Belardi D,Ren S,Rodriguez ER,Bedja D,Gabrielson KL,Wang Y,Kass DA.Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.Nat Med. 2005;11:214-22
17. Hou J,Kang YJ.Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.Pharmacol Ther. 2012;135:337-54
18. Hoffmann P,Richards D,Heinroth-Hoffmann I,Mathias P,Wey H,Toraason M.Arachidonic acid disrupts calcium dynamics in neonatal rat cardiac myocytes.Cardiovasc Res. 1995;30:889-98
19. Siddiqui RA,Shaikh SR,Kovacs R,Stillwell W,Zaloga G.Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid.J Cell Biochem. 2004;92:1141-59
20. Barron M,Gao M,Lough J.Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative.Dev Dyn. 2000;218:383-93
21. Zuo X,Dong DY,Sun M,Xie HQ,Kang YJ.Homocysteine restricts copper availability leading to suppression of cytochrome c oxidase activity in phenylephrine-treated cardiomyocytes.PLoS One. 2013;8:e67549-e67549
22. Dong DY,Wang B,Yin W,Ding XQ,Yu JJ,Kang YJ.Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury.PLoS One. 2013;8:e76209-e76209
23. Lu Z,Hunter T.Degradation of activated protein kinases by ubiquitination.Annu Rev Biochem. 2009;78:435-75
24. Kobayashi S,Sawano A,Nojima Y,Shibuya M,Maru Y.The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).FASEB J. 2004;18:929-31
25. Singh AJ,Meyer RD,Band H,Rahimi N.The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation.Mol Biol Cell. 2005;16:2106-18
26. Meyer RD,Srinivasan S,Singh AJ,Mahoney JE,Gharahassanlou KR,Rahimi N.PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation.Mol Cell Biol. 2011;31:2010-25
27. Suzuki Y,Nakabayashi Y,Nakata K,Reed JC,Takahashi R.X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes.J Biol Chem. 2000;276:27058-63
28. Kaur S,Wang F,Venkatraman M,Arsura M.X-linked Inhibitor of Apoptosis (XIAP) Inhibits c-Jun N-terminal Kinase 1 (JNK1) activation by Transforming Growth Factor β1 (TGF-β1) through ubiquitin-mediated proteosomal degradation of the TGF-β1-activated Kinase 1 (TAK1).J Biol Chem. 2005;280:38599-608
29. Brady GF,Galbán S,Liu X,Basrur V,Gitlin JD,Elenitoba-Johnson KS,Wilson TE,Duckett CS.Regulation of the copper chaperone CCS by XIAP-mediated ubiquitination.Mol Cell Biol. 2010;30:1923-36
30. Aird KM,Ghanayem RB,Peplinski S,Lyerly HK,Devi GR.X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.Mol Cancer Ther. 2010;9:1432-42